| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Ernexa Therapeutics Inc.
13G/A
ERNA · 114082407
|
9.7% |
5/13/2026
Event 2/10/2026
|
||||
| Shameek Konar | 9.7% | |||||
| Victoria Konar | 9.7% | |||||
| Regolith Capital Investments LP | 9.7% | |||||
|
Ernexa Therapeutics Inc.
13G/A
ERNA · 114082308
|
7.1% |
12/16/2025
Event 6/30/2025
|
||||
| Shameek Konar | 7.1% | |||||
| Victoria Konar | 7.1% | |||||
| Regolith Capital Investments LP | 7.0% | |||||
|
Ernexa Therapeutics Inc.
13G
ERNA · 114082209
|
5.5% |
5/15/2025
Event 3/31/2025
|
||||
| Shameek Konar | 5.5% | |||||
| Victoria Konar | 5.5% | |||||
| Regolith Capital Investments LP | 5.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.